Hitachi has developed automated cell mass culture equipment for iPS cells through open innovation and collaboration with Kyoto University and Sumitomo Dainippon Pharma. We will contribute to regenerative medicine, which has received attention as a new medical field, to achieve radical cures.
https://ift.tt/2zynllm HitachiBrandChannel September 27, 2018 at 12:04AM
Keine Kommentare:
Kommentar veröffentlichen